136 related articles for article (PubMed ID: 3423520)
1. [Mucolytic and mucoregulatory agents].
Yernault JC
Rev Med Brux; 1987 Oct; 8(8):423. PubMed ID: 3423520
[No Abstract] [Full Text] [Related]
2. The pharmacologic approach to airway clearance: mucoactive agents.
Rubin BK
Paediatr Respir Rev; 2006; 7 Suppl 1():S215-9. PubMed ID: 16798570
[TBL] [Abstract][Full Text] [Related]
3. [Clinical experience with a new mucus disolving agent (Bisolvon) for the therapy of whooping cough and diseases of the respiratory tract].
Ertogan F
Kinderarztl Prax; 1967 Apr; 35(4):141-6. PubMed ID: 5594869
[No Abstract] [Full Text] [Related]
4. [Mucolytics in acute and chronic respiratory tract disorders. I. Pathophysiology and mechanisms of action].
Kupczyk M; Kuna P
Pol Merkur Lekarski; 2002 Mar; 12(69):245-7. PubMed ID: 12053600
[TBL] [Abstract][Full Text] [Related]
5. [Use of the mucoregulator ascoril for respiratory diseases].
Shmeleva NM
Ter Arkh; 2012; 84(10):86-90. PubMed ID: 23227508
[TBL] [Abstract][Full Text] [Related]
6. Mucoactive agents for airway mucus hypersecretory diseases.
Rogers DF
Respir Care; 2007 Sep; 52(9):1176-93; discussion 1193-7. PubMed ID: 17716385
[TBL] [Abstract][Full Text] [Related]
7. [Mucolytic therapy for respiratory system diseases. Clinical-experimental results before and after treatment with Transbronchin].
Primer G
Ther Ggw; 1975 Aug; 114(8):1251-66. PubMed ID: 1108276
[No Abstract] [Full Text] [Related]
8. [Mucolytics in acute and chronic respiratory tract disorders. II. Uses for treatment and antioxidant properties].
Kupczyk M; Kuna P
Pol Merkur Lekarski; 2002 Mar; 12(69):248-52. PubMed ID: 12053601
[TBL] [Abstract][Full Text] [Related]
9. [Clinical trial of a new mucolytic, s-carboxymethylcysteine].
Ghillione de Torviso S
Arch Argent Pediatr; 1971 Aug; 69(6):247-8. PubMed ID: 4941345
[No Abstract] [Full Text] [Related]
10. [Therapeutic activity of an association of a mucolytic drug and a bronchodilator agent in the treatment of respiratory inflammations].
Boselli G
Minerva Med; 1973 Nov; 64(79):4128-37. PubMed ID: 4765427
[No Abstract] [Full Text] [Related]
11. Clinical evaluation of ascoxal a new mucolytic agent.
Fisher AJ; Ten Pas RH
Anesth Analg; 1966; 45(5):531-4. PubMed ID: 5330913
[No Abstract] [Full Text] [Related]
12. [Parenteral treatment of respiratory tract diseases with Bisolvone].
Stahlmann W; Siehoff F; Mathey HG; Schilling T; Weis H
Dtsch Med J; 1966 Aug; 17(16):478-80. PubMed ID: 5925468
[No Abstract] [Full Text] [Related]
13. Theory and practice of the use of expectorants reviewed from clinical aspects.
Nagy G
Ther Hung; 1984; 32(1):6-12. PubMed ID: 6400475
[No Abstract] [Full Text] [Related]
14. [Expectorants in the therapy of respiratory disease].
Ther Umsch; 1965 Jul; 22(7):392-402. PubMed ID: 5834882
[No Abstract] [Full Text] [Related]
15. [Effect of mucolytic agents in the management ofbronchial asthma. Personal experience with 20 cases].
Zenarruza GA
Prensa Med Argent; 1968 May; 55(14):657-8. PubMed ID: 5720924
[No Abstract] [Full Text] [Related]
16. The evaluation of mucolytic drugs in chronic bronchitis.
Shelley JH
Br J Clin Pract; 1970 Dec; 24(12):533-8. PubMed ID: 4924491
[No Abstract] [Full Text] [Related]
17. Clinical evaluation of new therapies for treatment of mucus hypersecretion in respiratory diseases.
Disse B
Novartis Found Symp; 2002; 248():254-72; discussion 272-6, 277-82. PubMed ID: 12568499
[TBL] [Abstract][Full Text] [Related]
18. Nesosteine: a new mucoregulatory agent.
Scuri R; Mondani P; Frova C; Fantini L
Drugs Exp Clin Res; 1986; 12(8):663-70. PubMed ID: 3757762
[TBL] [Abstract][Full Text] [Related]
19. The mucolytic effect of Sputolosin in horses with respiratory disease.
Matthews AG; Hackett IJ; Lawton WA
Vet Rec; 1988 Jan; 122(5):106-8. PubMed ID: 3363832
[TBL] [Abstract][Full Text] [Related]
20. The use of expectorants.
Hirsch SR
Wis Med J; 1971 May; 70(5):153-6. PubMed ID: 4941901
[No Abstract] [Full Text] [Related]
[Next] [New Search]
